Viromed Medical

Executive board member Perbandt, Uwe, sold a total of 80,000 Viromed Medical shares at €6.95 each on 25 August 2026; the transaction was reported on 28 August 2026. After the announcement the share fell sharply in FSE trading, at times trading between €6.30 and €6.80. Viromed Medical currently has a market value of around €129.60 million with 20,250,000 tradable shares; prior to that a closely connected person sold 7,500 shares at €7.05 on 24 August 2026. » Altro su finanzen.net

Heike Perbandt sold a total of 7,500 Viromed Medical shares at €7.05 each on 24 August 2026; previously she had already disposed of 10,000 shares at €7.10 each on 20 August 2026. The stock reacted with losses and traded on the FSE around the day of the disclosure between €6.80 and €6.85. Viromed Medical’s market capitalization currently stands at around €142.76 million, and 20,250,000 shares are tradable. » Altro su finanzen.net

At Viromed Medical, a closely related executive, Perbandt Heike, sold 10,000 shares on 20.08.2026 at a price of EUR 7.10 each; the transaction was reported on 25.08.2026. On the day of publication the shares fell briefly in FSE trading and later closed at EUR 6.80, having traded earlier between EUR 7.20 and EUR 7.70; 170 shares changed hands that trading day. Already on 06.08.2026, board member Perbandt Uwe had reduced his holding by 50,000 shares at EUR 7.70. Viromed Medical has a market capitalization of around EUR 142.76 million and a free float of 20,250,000 shares. » Altro su finanzen.net